Quidel and OPKO Health Are Scoring With Coronavirus Testing in Sports. Is the Market Missing It?
After shutting down its season on March 11, the NBA resumed games four months later, isolated in a Walt Disney World complex. After that four-month experiment in sequestering teams, coaches, and families from interaction with the public, the league has a champion -- and zero positive coronavirus tests.
An accomplishment like this obviously takes a lot of coordination, a little luck, and a lot of testing. The NBA originally partnered with Quest Diagnostics (NYSE: DGX), and later switched to OPKO Health's (NASDAQ: OPK) BioReference Laboratories. While not every sport is taking the same approach as the NBA did with its bubble (or having the same success), testing has been a key component of bringing sports back.
Despite a fragmented diagnostics market, Quidel (NASDAQ: QDEL) and OPKO Heath are fast becoming the face of sports leagues' testing plans for making sure professional and college athletes are able to play safely.
Source Fool.com
